Still Using Tablets in Your Clinical Trials? Consider Changing to a Better Option.

 

Accelerate Your Clinical Trials With This Dosage Form

With tablets presenting numerous drawbacks, liquid-filled capsules (LFCs) are becoming the optimal choice for clinical trials. Their benefits include:

• Ease of scalability from preclinical to clinical to commercial volumes
• Quick dose adjustments
• Faster dissolution and absorption
• Less required stability studies 

LFCs are most suitable for drugs with complex formulations, low-dose requirements, poor solubility, or highly potent active pharmaceutical ingredients (APIs). Clients with such drug profiles substantially accelerated their drug development process using LFCs for early phase clinical trials, resulting in reduced costs.

Where Do We Come In?

Altasciences’ state-of-the-art cGMP manufacturing and analytical facility in Philadelphia has a team of experienced scientists to support you through your entire drug development process, from pre-formulation to clinical trials and beyond. Our advanced equipment includes cutting-edge liquid-filling, binding, and sealing machines, ensuring an impressive 97% right-first-time (RFT) batch release success rate.

Consult our resources for further details on how you can benefit from using LFCs in your clinical trials.

eBooklet (PDF)	Infographic (PDF)	Quick Chat (Video)	Client Case Study (PDF)

Ready to accelerate your drug development? Speak with one of our experts.

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.